The Journal of Internal Korean Medicine (대한한방내과학회지)

The Society of Internal Korean Medicine (대한한방내과학회)
권호 표지
DOI QR코드

DOI QR Code

A Case Report of Chronic Chemotherapy-Induced Peripheral Neuropathy Treated by Korean Traditional Medicine

항암화학요법으로 유발된 만성 말초신경병증 환자의 한의학적 치험 1례 : 2년 이상 지속된 항암화학요법 유발 말초신경병증 치험

  • An, Yu-min (Dept. of Cardiovascular and Neurologic Diseases of Korean Internal Medicine, Daegu Korean Medicine Hospital of Daegu Haany University) ;
  • Lee, Yoo-Na (Dept. of Cardiovascular and Neurologic Diseases of Korean Internal Medicine, Daegu Korean Medicine Hospital of Daegu Haany University) ;
  • Baek, Kyungmin (Dept. of Cardiovascular and Neurologic Diseases of Korean Internal Medicine, Daegu Korean Medicine Hospital of Daegu Haany University) ;
  • Jang, Woo-Seok (Dept. of Cardiovascular and Neurologic Diseases of Korean Internal Medicine, Daegu Korean Medicine Hospital of Daegu Haany University)
  • 안유민 (대구한의대학교 부속 대구한방병원 심계내과학교실) ;
  • 이유나 (대구한의대학교 부속 대구한방병원 심계내과학교실) ;
  • 백경민 (대구한의대학교 부속 대구한방병원 심계내과학교실) ;
  • 장우석 (대구한의대학교 부속 대구한방병원 심계내과학교실)
  • Received : 2020.09.24
  • Accepted : 2020.11.01
  • Published : 2020.10.30
Download PDF
⟨ Previous Next ⟩

Abstract

Objective: This study reports the effect of Korean traditional medicine on persistent chemotherapy-induced peripheral neuropathy (CIPN). Methods: The patient was treated with Korean traditional medicine that included acupuncture, moxibustion, and herbal medicine. The effectiveness of the treatment was evaluated by the Quality of Life Questionnaire-Core 30 (QLQ-C30), the Quality of Life Questionnaire Chemotherapy-Induced Peripheral Neuropathy (QLQ-CIPN20), the Medicinae Doctor Anderson Symptom Inventory (MDASI), and a numeral rating scale (NRS). We also used the Beck Depression Inventory (BDI) to evaluate the patient's mood change after relieving the paresthesia. Results: After treatment, the symptoms were improved. Paresthesia decreased 80%p after Korean medicine treatment. Conclusions: According to this study, Korean traditional medicine can be an effective treatment for paresthesia in patients suffering from CIPN over 2 years.

Keywords

References

  1. Statistics Korea. Cancer Incidence and Death Status [accessed September 2020]. Available from: https://www.index.go.kr/potal/main/EachDtlPageDetail.do?idx_cd=2770#quick_02;
  2. Statistics Korea. 5 year disease free survival rates [accessed September 2020]. Available from: https://www.index.go.kr/unify/idx-info.do?idxCd=4241
  3. Woo IS. Recent Updates on Chemotherapy-Induced Peripheral Neuropathy. Korean J Med 2015;88(1):35-7. https://doi.org/10.3904/kjm.2015.88.1.35
  4. Seretny M, Currie GL, Sena ES, Ramnarine S, Grant R, MacLeod MR, et al. Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: A systematic review and meta-analysis. PAIN 2014;155(12):2461-70. https://doi.org/10.1016/j.pain.2014.09.020
  5. Park SB, Goldstein D, Krishnan AV, Lin CSY, Friedlander ML, Cassidy J, et al. Chemotherapy -Induced Peripheral Neurotoxicity: A Critical Analysis. Cancer J Clin 2013;63(6):419-37. https://doi.org/10.3322/caac.21204
  6. Richardson PG, Briemberg H, Jagannath S, Wen PY, Barlogie B, Berenson J et al. Frequency, characteristics, and reversibility of peripheral neuropathy during treatment of advanced multiple myeloma with bortezomib. J Clin Oncol 2006;24(19):3113-20. https://doi.org/10.1200/JCO.2005.04.7779
  7. Kerckhove N, Collin A, Conde S, Chaleteix C, Peze D, Balayssac D. Long-Term Effects, Pathophysiological Mechanisms, and Risk Factors of Chemotherapy-Induced Peripheral Neuropathies: A Comprehensive Literature Review. Frontiers in Pharmacology 2017;8(86):1-17.
  8. Fayers PM, Aaronson NK, Bjordal K, Groenvold M, Curran D, Bottomley A. The EORTC QLQ-C30 Scoring Manual. 3rd Edit. Brussels: European Organisation for Research and Treatment of Cancer; 2001, p. 1-12.
  9. Smith EML, Barton DL, Qin R, Steen PD, Aaronson NK, Loprinzi CL, et al. Assessing patient-reported peripheral neuropathy: the reliability and validity of the European Organization for Research and Treatment of Cancer QLQ-CIPN20 Questionnaire. Quality of Life Research. 2013;22(10):2787-99. https://doi.org/10.1007/s11136-013-0379-8
  10. Yun YH, Mendoza TR, Kang IO, You CH, Roh JW, Lee CG, et al. Validation Study of the Korean Version of the M. D. Anderson Symptom Inventory. J of Pain and Symptom Management 2006;31(4):345-52. https://doi.org/10.1016/j.jpainsymman.2005.07.013
  11. Lazaridou A, Elbaridi N, Edwards RR, Berde CB. Essentials of Pain Medicine. 4th Edition. Philadelphia: Elsevier; 2018, p. 39-46.
  12. Yoon SY, Lim JH, Han CS. Rating Scales for Measurement-Based Clinical Practice of Depression. The Korean J of Psychopharmacology 2012;23(4):136-46.
  13. Leppert W. Role of oxycodone and oxycodone/naloxone in cancer pain management. Pharmacological Report 2010;62(4):578-91. https://doi.org/10.1016/S1734-1140(10)70316-9
  14. Zajaczkowska R, Kocot-Kepska M, Leppert W, Wrzosek A, Mika J, Wordliczek J. Mechanisms of Chemotherapy-Induced Peripheral Neuropathy. International J of Molecular Sciences 2019; 20(6):1451-79. https://doi.org/10.3390/ijms20061451
  15. Jo KH, Goh HY, Gwon JN, Kim YS, Park SW, Baek GM, et al. Textbook of Korean Internal medicine of Cardiology and Neurology. 3rd rev. Seoul: Koonja; 2013, p. 416-9, 422.
  16. Kook YB, Kim SC, Park SD, Park SG, Seo BI, Seo YB, et al. Text Book of the Herbal Formula Study. 4th rev. Seoul: Yunglimsa; 2008, p. 268-9.
  17. Litscher G, Wang L, Huber E, Nilsson G. Changed skin blood perfusion in the fingertip following acupuncture needle introduction as evaluated by laser Doppler perfusion imaging. Lasers in medical science 2002;17(1):19-25. https://doi.org/10.1007/s10103-002-8262-9
  18. Ma S, Cornford ME, Vahabnezhad I, Wei S, Li X. Responses of nitric oxide synthase expression in the gracile nucleus to sciatic nerve injury in young and aged rats. Brain research 2000;855(1):124-31. https://doi.org/10.1016/S0006-8993(99)02379-3
  19. Ogawa K, Ogawa M, Nishijima K, Tsuda M, Nishimura G. Efficacy of contact needle therapy for chemotherapy-induced peripheral neuropathy. Evidence-Based Complementary and Alternative Medicine 2013;2013:928129. https://doi.org/10.1155/2013/928129
  20. Stubblefield MD, Burstein HJ, Burton AW, Custodio CM, Deng GE, Ho M, et al. NCCN task force report: management of neuropathy in cancer. J of the National Comprehensive Cancer Network 2009;7(5):S1-S26.
  21. Kim EH, Yoon JH, Lee JY, Yoon SW. The Therapeutic Eficacy of Acupuncture for Chemotherapy-Induced Peripheral Neuropathy:A Systematic Review and Meta-Analysis. J Int Korean Med 2020;41(3):350-61. https://doi.org/10.22246/jikm.2020.41.3.350
  22. Lim YK, Park HJ, Lee HS, Lee HJ, Lim SBN, Chae YB, et al. Details of Meridians & Acupoints. 6st rev. Daejeon: Jonglyeonamu; 2012, p. 213-30, 1168, 1186.
  23. Wang Y, Zhang Y, Wang W, Cao Y, Han JS. Effects of synchronous or asynchronous electroacupuncture stimulation with low versus high frequency on spinal opioid release and tail flick nociception. Exp Neurol 2005;192(1):156-62. https://doi.org/10.1016/j.expneurol.2004.11.003